🇺🇸 FDA
Patent

US 6521417

Engineered protein kinases which can utilize modified nucleotide triphosphate substrates

expired A61KA61K38/00A61P

Quick answer

US patent 6521417 (Engineered protein kinases which can utilize modified nucleotide triphosphate substrates) held by THE TRUSTEES OF PRINCETON UNIVERSITY expires Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
THE TRUSTEES OF PRINCETON UNIVERSITY
Grant date
Tue Feb 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61P, A61P25/28, A61P31/18